Druley brings to the role his vast experience in molecular diagnostics and building clinical programs, the company said in a press release. Prior to joining Mission Bio, Druley held CMO roles at Angle Biosciences and ArcherDX. He is also currently a scientific advisor for RhoDx.

Since 2016, he has also worked with Mission Bio's Tapestry Platform, the company's multi-omics platform that can analyze DNA and protein simultaneously from the same sample at single-cell resolution.

Mission Bio builds on Tapestri Platform
Mission Bio has added new features to its Tapestri Platform aimed at supporting research in solid tumors.

Mission Bio announces its 1st single-cell Tapestri Center of Excellence
Mission Bio has announced its first Center of Excellence, located at Memorial Sloan Kettering Cancer Center (MSK). As the first single-cell Tapestri Center...

Researchers identify BTK inhibitor-resistant clones with Mission Bio
Mission Bio, in conjunction with researchers at Memorial Sloan Kettering Cancer Center and the University of Miami, has published new findings showing...

Mission Bio transfers 1st Tapestri GMP-ready CGT assay
Mission Bio has completed the first tech transfer of a clinical trial-, good manufacturing practices (GMP)-ready cell and gene therapy (CGT) assay from...